Broad spectrum immunomodulatory effects of Anopheles gambiae microRNAs and their use for transgenic suppression of Plasmodium.
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
20
08
2019
accepted:
03
03
2020
revised:
06
05
2020
pubmed:
25
4
2020
medline:
28
7
2020
entrez:
25
4
2020
Statut:
epublish
Résumé
Malaria, caused by the protozoan parasite Plasmodium and transmitted by Anopheles mosquitoes, represents a major threat to human health. Plasmodium's infection cycle in the Anopheles vector is critical for transmission of the parasite between humans. The midgut-stage bottleneck of infection is largely imposed by the mosquito's innate immune system. microRNAs (miRNAs, small noncoding RNAs that bind to target RNAs to regulate gene expression) are also involved in regulating immunity and the anti-Plasmodium defense in mosquitoes. Here, we characterized the mosquito's miRNA responses to Plasmodium infection using an improved crosslinking and immunoprecipitation (CLIP) method, termed covalent ligation of endogenous Argonaute-bound RNAs (CLEAR)-CLIP. Three candidate miRNAs' influence on P. falciparum infection and midgut microbiota was studied through transgenically expressed miRNA sponges (miR-SPs) in midgut and fat body tissues. MiR-SPs mediated conditional depletion of aga-miR-14 or aga-miR-305, but not aga-miR-8, increased mosquito resistance to both P. falciparum and P. berghei infection, and enhanced the mosquitoes' antibacterial defenses. Transcriptome analysis revealed that depletion of aga-miR-14 or aga-miR-305 resulted in an increased expression of multiple immunity-related and anti-Plasmodium genes in mosquito midguts. The overall fitness cost of conditionally expressed miR-SPs was low, with only one of eight fitness parameters being adversely affected. Taken together, our results demonstrate that targeting mosquito miRNA by conditional expression of miR-SPs may have potential for the development of malaria control through genetically engineered mosquitoes.
Identifiants
pubmed: 32330198
doi: 10.1371/journal.ppat.1008453
pii: PPATHOGENS-D-19-01552
pmc: PMC7202664
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1008453Subventions
Organisme : NIAID NIH HHS
ID : R01 AI122743
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI113989
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Nat Commun. 2015 Nov 25;6:8864
pubmed: 26602609
Cell. 2013 Apr 25;153(3):654-65
pubmed: 23622248
Mol Cells. 2016 May 31;39(5):375-81
pubmed: 27117456
Dev Comp Immunol. 2015 Mar;49(1):170-8
pubmed: 25445902
Curr Biol. 2003 Apr 29;13(9):790-5
pubmed: 12725740
J Innate Immun. 2014;6(2):169-81
pubmed: 23988482
Am J Trop Med Hyg. 2007 Jun;76(6):1118-24
pubmed: 17556621
Nat Rev Genet. 2011 Feb;12(2):99-110
pubmed: 21245828
Genes Dev. 2014 Nov 1;28(21):2421-31
pubmed: 25367037
Science. 2011 May 13;332(6031):855-8
pubmed: 21566196
Pathog Glob Health. 2017 Dec;111(8):424-435
pubmed: 29385893
PLoS Pathog. 2009 Sep;5(9):e1000576
pubmed: 19750215
Nat Rev Genet. 2015 Jul;16(7):421-33
pubmed: 26077373
Rev Inst Med Trop Sao Paulo. 2012 Sep-Oct;54(5):287-92
pubmed: 22983293
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):E1895-E1903
pubmed: 28223504
Insect Biochem Mol Biol. 2009 Dec;39(12):903-12
pubmed: 19883761
PLoS Negl Trop Dis. 2018 May 2;12(5):e0006463
pubmed: 29718912
PLoS Pathog. 2018 Mar 8;14(3):e1006898
pubmed: 29518156
Nucleic Acids Res. 2007;35(20):6953-62
pubmed: 17933784
Trends Parasitol. 2018 Jul;34(7):603-616
pubmed: 29793806
Nature. 2009 Jul 23;460(7254):479-86
pubmed: 19536157
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11508-13
pubmed: 9326640
BMC Genomics. 2014 Jul 04;15:557
pubmed: 24997592
Cell. 2004 Mar 5;116(5):661-70
pubmed: 15006349
PLoS Pathog. 2011 Dec;7(12):e1002458
pubmed: 22216006
Trends Parasitol. 2006 May;22(5):197-202
pubmed: 16564223
Biology (Basel). 2012 Dec 14;1(3):895-905
pubmed: 24832523
Malar J. 2013 Apr 26;12:142
pubmed: 23622561
Sci Rep. 2017 Jul 26;7(1):6493
pubmed: 28747726
Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):E6736-43
pubmed: 26598698
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):E4828-36
pubmed: 27489347
G3 (Bethesda). 2018 Jan 4;8(1):185-193
pubmed: 29146584
Nat Struct Mol Biol. 2012 Feb 12;19(3):321-7
pubmed: 22343717
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1440-5
pubmed: 25605933
Nat Methods. 2009 Dec;6(12):897-903
pubmed: 19915559
Mem Inst Oswaldo Cruz. 2014 Aug;109(5):644-61
pubmed: 25185005
Nat Biotechnol. 2018 Dec;36(11):1062-1066
pubmed: 30247490
Mol Cell. 2014 Jun 19;54(6):1042-1054
pubmed: 24857550
G3 (Bethesda). 2015 Apr 13;5(6):1151-63
pubmed: 25869647
Nature. 2003 Sep 25;425(6956):415-9
pubmed: 14508493
BMC Genomics. 2009 Dec 04;10:581
pubmed: 19961592
Sci Rep. 2016 Nov 18;6:36625
pubmed: 27857164
PLoS Pathog. 2012;8(8):e1002884
pubmed: 22927820
Parasite Immunol. 2017 Feb;39(2):
pubmed: 28299810
Nat Protoc. 2014 Mar;9(3):711-28
pubmed: 24577361
Cell Microbiol. 2002 Nov;4(11):713-24
pubmed: 12427094
Nat Struct Mol Biol. 2010 Feb;17(2):173-9
pubmed: 20062054
PLoS Pathog. 2006 Jun;2(6):e52
pubmed: 16789837
Science. 2017 Sep 29;357(6358):1396-1399
pubmed: 28963254
Nat Methods. 2007 Sep;4(9):721-6
pubmed: 17694064
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712